🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study is to evaluate in a 3 +3 design, the safety of ...
Status
Completed
Location
University of California, Moores Cancer Center
Start Date
2015-12
Trial ID
NCT02643550
Treatments Being Tested
This is a Phase 1/2 study of HST-1011, a CBL-B inhibitor, being developed f...
Status
Active Not Recruiting
Location
Florida Cancer Specialists
Start Date
2023-03-15
Trial ID
NCT05662397
Treatments Being Tested
This study will evaluate efficacy and safety of anti-PD-1/PD-L1 antibodies ...
Status
Recruiting
Location
EuroCityClinic LLC
Start Date
2025-08-14
Trial ID
NCT07130032
Treatments Being Tested
This phase II trial tests how well a combination of three immunotherapy dru...
Status
Active Not Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-11-08
Trial ID
NCT06056895
This is a Phase III, multicentre, randomised, double-blind, placebo-control...
Status
Completed
Location
Sir Run Run Shaw Hospital, Zhejiang University 浙江大学医学院附属邵逸夫医院
Start Date
2019-08-01
Trial ID
NCT03881371
Treatments Being Tested
This is a single-center, open-label, Phase 2 study to evaluate the efficacy...
Status
Recruiting
Location
Asan Medical Center
Start Date
2023-03-08
Trial ID
NCT05533983
Treatments Being Tested
This is a phase 1b/2 study to evaluate the safety and efficacy of metronomi...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-12
Trial ID
NCT03167164
The goal of this study is to see if the drug balstilimab is safe and effect...
Status
Recruiting
Location
Hematology Center named after prof. R. Yeolyan
Start Date
2023-09-01
Trial ID
NCT05891821
Treatments Being Tested
A first-in-human, Phase 1, open-label, multicenter study of WTX-330 adminis...
Status
Completed
Location
HonorHealth
Start Date
2022-12-06
Trial ID
NCT05678998
Treatments Being Tested
The purpose of this study is to determine the safety, feasibility, recommen...
Status
Recruiting
Location
NYU Langone Health
Start Date
2024-04-10
Trial ID
NCT06311578
Treatments Being Tested